LON:POLX

Polarean Imaging (POLX) Share Forecast, Price & News

GBX 49

0.00 (0.00%)

(As of 05/13/2022 05:06 PM ET)

Add

Compare

Today's Range: 48
▼
50
50-Day Range: 48.38
▼
67
52-Week Range: 35
▼
113

Volume: 230,807 shs
Average Volume: 347,900 shs
Market Capitalization: £104.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive POLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter.

About Polarean Imaging

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

April 20, 2022 | proactiveinvestors.com

Polarean Imaging says US regulator accepts updated submission

April 14, 2022 | proactiveinvestors.com

Polarean Imaging appoints former GE Healthcare exec as an independent director

April 14, 2022 | proactiveinvestors.com

Polarean Imaging appoints former GE Healthcare exec as independent director

April 9, 2022 | lse.co.uk

Polarean Imag. Share Chat

March 31, 2022 | proactiveinvestors.com

Polarean Imaging upbeat as it resubmits new drug application to US FDA

March 3, 2022 | uk.investing.com

Polarean Imaging Plc (POLX)

February 15, 2022 | lse.co.uk

Polarean Imag. Regulatory News

February 14, 2022 | finance.yahoo.com

We're Not Very Worried About Polarean Imaging's (LON:POLX) Cash Burn Rate

February 14, 2022 | proactiveinvestors.com

Polarean Imaging says Canada's McMaster University orders additional kit

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:POLX
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.polarean.com
Phone: 919 206 7900
Fax: N/A
Employees: 21
Year Founded: N/A

Sales & Book Value

Annual Sales: £1.35 million
Price / Sales: 77.07
Cash Flow: GBX 18.20 per share
Price / Cash Flow: 2.69
Book Value: GBX 18.90 per share
Price / Book: 2.59

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.40
Current Ratio: 14.70
Quick Ratio: 14.24

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 212,440,000
Free Float: N/A
Market Cap: £104.10 million
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Polarean Imaging.

4.5 Community Rank

Outperform Votes
Polarean Imaging has received 23 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Polarean Imaging has received 11 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Polarean Imaging has received 67.65% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Polarean Imaging and other stocks. Vote “Outperform” if you believe POLX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe POLX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Polarean Imaging does not currently pay a dividend.
Dividend Growth
Polarean Imaging does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Polarean Imaging insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Polarean Imaging is -12.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Polarean Imaging is -12.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Polarean Imaging has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Polarean Imaging (LON:POLX) Frequently Asked Questions

Who are Polarean Imaging's key executives?: Polarean Imaging's management team includes the following people:
Mr. Clairis Richard Hullihen, CEO & Director (Age 69, Pay $293.55k)
Dr. Bastiaan Driehuys Ph.D., Founder, CTO & Director (Age 53, Pay $50k)
Mr. Kenneth Paul West, Consultant & Non-Exec. Director (Age 65, Pay $123.93k)
Mr. Charles Fremont Osborne Jr., CFO & Director (Age 56)
Mr. Neil Wadehra, VP of Operations (Age 42)
Mr. Alex Dusek, Chief Commercial Officer (Age 55)
Mr. Stephen Austin, Company Sec.
Who are some of Polarean Imaging's key competitors?: Some companies that are related to Polarean Imaging include Avacta Group (AVCT), Viemed Healthcare (VMD), Protech Home Medical (PTQ), Hamilton Thorne (HTL), Medica Group (MGP), Viemed Healthcare (VMD), Creo Medical (CREO), Advanced Oncotherapy (AVO), Asensus Surgical (ASXC), MRI Interventions (MRIC), Inspiration Healthcare Group (IHC), Titan Medical (TMD), Protech Home Medical (PHM), Helius Medical Technologies (HSM) and Intelligent Ultrasound Group (IUG).
View all of POLX's competitors.
What other stocks do shareholders of Polarean Imaging own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP).
What is Polarean Imaging's stock symbol?: Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX."
How do I buy shares of Polarean Imaging?: Shares of POLX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Polarean Imaging's stock price today?: One share of POLX stock can currently be purchased for approximately GBX 49.
How much money does Polarean Imaging make?: Polarean Imaging has a market capitalization of £104.10 million and generates £1.35 million in revenue each year.
How many employees does Polarean Imaging have?: Polarean Imaging employs 21 workers across the globe.
What is Polarean Imaging's official website?: The official website for Polarean Imaging is www.polarean.com.
How can I contact Polarean Imaging?: The company can be reached via phone at 919 206 7900.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.